Search research articles
Contact Us
Filters
Showing results (21-30 of 298) with videos related to
Page
of 30
Sort By:
JNCI Cancer Spectrum
|
July 31, 2019
Defining a Clinically Meaningful Benefit in Cancer Clinical Trials: From the Perspectives of the Clinical Trialist, Patient, and Society
Dominic H Moon, Ronald C Chen
International Journal of Radiation Oncology, Biology, Physics
|
July 23, 2019
Partial Prostate Cancer Treatment for Aggressive Disease-Common Practice
Dominic H Moon, Ronald C Chen
Urologic Oncology
|
January 28, 2016
Adjuvant vs.salvage radiotherapy for patients at high risk for recurrence after radical prostatectomy
Aaron D Falchook, Ronald C Chen
Seminars in Radiation Oncology
|
June 15, 2013
Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer
Kevin A Pearlstein, Ronald C Chen
International Journal of Radiation Oncology, Biology, Physics
|
November 17, 2022
The Cost-Effectiveness of Consolidative Radiation Therapy in Oligometastatic Disease: High-Value Proposition or Wishful Thinking?
David J Sher, Ronald C Chen
International Journal of Radiation Oncology, Biology, Physics
|
June 5, 2021
Understanding Competing Risks
Ramsankar Basak, Hitesh Mistry, Ronald C Chen
Acta Oncologica (Stockholm, Sweden)
|
January 14, 2017
Patient-reported outcomes in cancer survivorship
Brittaney-Belle E Gordon, Ronald C Chen
International Journal of Radiation Oncology, Biology, Physics
|
September 6, 2025
Long-Term Outcomes in Hypofractionated Postprostatectomy Radiation: Cautionary Tale or Expected Findings?
Xinglei Shen, Ronald C Chen, Mark K Buyyounouski
JAMA Oncology
|
November 29, 2016
Androgen Deprivation Therapy and Dose-Escalated Radiotherapy for Intermediate- and High-Risk Prostate Cancer-Reply
Aaron D Falchook, Ramsankar Basak, Ronald C Chen
The Oncologist
|
June 27, 2024
Why is a small sample size not enough?
Ying Cao, Ronald C Chen, Aaron J Katz
Page
of 30
Search research articles
Search
Showing results (21-30 of 298) with videos related to
Sort By:
Page
of 30
JNCI Cancer Spectrum
|
July 31, 2019
Defining a Clinically Meaningful Benefit in Cancer Clinical Trials: From the Perspectives of the Clinical Trialist, Patient, and Society
Dominic H Moon, Ronald C Chen
International Journal of Radiation Oncology, Biology, Physics
|
July 23, 2019
Partial Prostate Cancer Treatment for Aggressive Disease-Common Practice
Dominic H Moon, Ronald C Chen
Urologic Oncology
|
January 28, 2016
Adjuvant vs.salvage radiotherapy for patients at high risk for recurrence after radical prostatectomy
Aaron D Falchook, Ronald C Chen
Seminars in Radiation Oncology
|
June 15, 2013
Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer
Kevin A Pearlstein, Ronald C Chen
International Journal of Radiation Oncology, Biology, Physics
|
November 17, 2022
The Cost-Effectiveness of Consolidative Radiation Therapy in Oligometastatic Disease: High-Value Proposition or Wishful Thinking?
David J Sher, Ronald C Chen
International Journal of Radiation Oncology, Biology, Physics
|
June 5, 2021
Understanding Competing Risks
Ramsankar Basak, Hitesh Mistry, Ronald C Chen
Acta Oncologica (Stockholm, Sweden)
|
January 14, 2017
Patient-reported outcomes in cancer survivorship
Brittaney-Belle E Gordon, Ronald C Chen
International Journal of Radiation Oncology, Biology, Physics
|
September 6, 2025
Long-Term Outcomes in Hypofractionated Postprostatectomy Radiation: Cautionary Tale or Expected Findings?
Xinglei Shen, Ronald C Chen, Mark K Buyyounouski
JAMA Oncology
|
November 29, 2016
Androgen Deprivation Therapy and Dose-Escalated Radiotherapy for Intermediate- and High-Risk Prostate Cancer-Reply
Aaron D Falchook, Ramsankar Basak, Ronald C Chen
The Oncologist
|
June 27, 2024
Why is a small sample size not enough?
Ying Cao, Ronald C Chen, Aaron J Katz
Page
of 30